Eprcomunicazione spa (EPRB) News

Trump Media Resells Stocks and Warrants; KB Home Exceeds Q2 Expectations, and More News

Trump Media & Technology Group (NASDAQ:DJT) – Trump Media & Technology Group announced that the...

Fisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and More

Fisker (NYSE:FSR) – The American electric vehicle manufacturer filed for bankruptcy last night, aiming...

Goldman Sachs Raises S&P 500 Forecast for 2024; Disney Secures Deadpool & Wolverine in Chinese Cinemas, and More

Walt Disney (NYSE:DIS) – Disney managed to secure the release of Deadpool & Wolverine in Chinese...

Adobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and More

Adobe (NASDAQ:ADBE) – Adobe exceeded expectations in the last quarter with revenue of $5.31 billion...

Form 8-K - Current report

Tesla Releases Results of 2024 Annual Meeting of Stockholders

Tesla Is Now a Texas Corporation At today’s Annual Stockholders’ Meeting, Tesla stockholders overwhelmingly approved the ratification of the 2018...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Tesla Surges 5% in Pre-Market; Virgin Galactic Drops 9% Following Reverse Stock Split, and More News

Virgin Galactic (NYSE:SPCE) – Virgin Galactic shares fell 9.1% in pre-market trading after announcing a...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Paramount Ends Skydance Talks, Oracle Shares Surge 8.7% on New Partnerships, and More News

Paramount Global (NASDAQ:PARA) – National Amusements ended negotiations with Skydance for a merger with...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form PX14A6G - Notice of exempt solicitation submitted by non-management

FDA Panel Supports Eli Lilly’s Donanemab, Rio Tinto Expands Stake in Boyne Smelters, and More News

Eli Lilly (NYSE:LLY) – Eli Lilly’s experimental Alzheimer’s drug, donanemab, has received...